IcICLLe: Assessment of the Mechanism of Action of Ibrutinib (PCI-32765) in B-cell Receptor Pathway Inhibition in CLL

  • Siddique, Shamyla (Co-Investigator)
  • Fenwick, Nicola (Principal Investigator)

Project Details

Short titleIcICLLe: Assessment of the Mechanism of Action of Ibrutinib (PCI-32765) in B-cell Receptor Pathway Inhibition in CLL
StatusActive
Effective start/end date14/03/1431/12/23

Funding

  • PHARMACYCLICS INC